| Financial Year |
March 31 2023 |
| Monetary Funds |
1,332,242,246.33 |
| Held-for-trading Financial Assets |
25,691,779.02 |
| Notes Receivable |
-- |
| Accounts Receivable |
474,528,714.19 |
| Advances to Suppliers |
561,008,908.21 |
| Other Receivables |
92,822,797.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,700,274.71 |
| Inventories |
74,776,200.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,939,841.32 |
| Total Current Assets |
2,662,865,936.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,304,365,017.05 |
| Investment Properties |
59,078,118.39 |
| Fixed Assetes |
4,631,761,172.40 |
| Under-construction Projects |
834,725,943.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
370,838,723.32 |
| R&D expenses |
-- |
| Goodwill |
72,141,182.76 |
| Long-Term Deferred and Prepaid Expenses |
11,866,327.06 |
| Deferred Income Tax Assets |
159,544,968.23 |
| Other Non-Current Assets |
4,965,224.40 |
| Sub-Total of Non-Current Assets |
7,498,667,850.27 |
| Total Assets |
10,161,533,786.93 |
| Short-Term Loans |
354,776,958.38 |
| Trading Financial liabilities |
-- |
| Notes Payable |
77,091,738.96 |
| Accounts Payable |
442,460,321.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
138,964,654.47 |
| Taxes Payable |
26,213,604.64 |
| Interest Payable |
-- |
| Dividend Payable |
15,079,413.42 |
| Other payables |
396,672,348.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,579,406.69 |
| Other Current Liabilities |
309,909,449.31 |
| Sub-Total of Current Liabilities |
3,264,052,730.19 |
| Long-term Loans |
118,831,447.56 |
| Bonds Payable |
502,304,109.59 |
| Long-Term Accounts Payable |
37,700,435.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,514,409.90 |
| Other Non-Current Liabilities |
791,067,395.49 |
| Sub-Total of Non-Current Liabilities |
1,605,017,896.54 |
| Total Liabilities |
4,869,070,626.73 |
| Paid-In Capital(Or Share Stock) |
1,571,340,000.00 |
| Capital Surplus |
1,070,801,631.08 |
| Surplus Reserve |
367,924,112.89 |
| LESS:Treasury Stock |
37,801,880.80 |
| Undistributed Profits |
1,892,757,776.72 |
| Minority Stockholder's Interest |
370,203,229.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,922,259,931.08 |
| Owner's Equity（Stockholder's Equity） |
5,292,463,160.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,161,533,786.93 |
